Astera Labs (NASDAQ:ALAB) Trading Up 9.8% – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB)’s share price was up 9.8% during trading on Friday . The company traded as high as $321.65 and last traded at $310.40. Approximately 6,271,666 shares changed hands during mid-day trading, an increase of 18% from the average session volume of 5,312,975 shares. The stock had previously closed at $282.82.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Wall Street Analyst Weigh In

Several research firms recently weighed in on ALAB. Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Evercore reiterated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. UBS Group restated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Stock Up 9.8%

The stock has a market capitalization of $53.85 billion, a PE ratio of 153.66 and a beta of 3.77. The stock’s 50 day moving average price is $330.74 and its 200-day moving average price is $254.36.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Activity

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 592,244 shares of company stock valued at $209,729,973. Insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently made changes to their positions in ALAB. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs during the fourth quarter valued at approximately $18,708,000. Swedbank AB lifted its holdings in Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in Astera Labs during the fourth quarter worth $499,000. Revere Asset Management Inc bought a new stake in Astera Labs during the 4th quarter valued at $589,000. Finally, Banque Cantonale Vaudoise boosted its position in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after acquiring an additional 3,229 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.